The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients

References

• McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006 Apr;163(4):600–610.
   PubMed Web of Science ®Google Scholar
• Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry. 2001 Apr;158(4):518–526.
   PubMed Web of Science ®Google Scholar
• Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019 Sep 14;394(10202):939–951. DOI:10.1016/S0140-6736(19)31135-3
   PubMed Web of Science ®Google Scholar
• Lally J, Gaughran F, Timms P, et al. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmgenomics Pers Med. 2016;9:117–129.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018 Jan;51(1–02):9–62.
   PubMed Web of Science ®Google Scholar
• Miller DD. Review and management of clozapine side effects. J Clin Psychiatry. 2000;61(8): 14–17. discussion 18-9.
   PubMedGoogle Scholar
• Skokou M, Karavia EA, Drakou Z, et al. Adverse drug reactions in relation to clozapine plasma levels: a systematic review. Pharmaceuticals (Basel). 2022 Jul 1;15(7):817. DOI:10.3390/ph15070817
   PubMedGoogle Scholar
• Gee S, Dixon T, Docherty M, et al. Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment. BMC Psychiatry. 2015 Aug 12;15(1):195. DOI:10.1186/s12888-015-0536-4
   PubMedGoogle Scholar
• Numata S, Umehara H, Ohmori T, et al. Clozapine pharmacogenetic studies in schizophrenia: efficacy and agranulocytosis. Front Pharmacol. 2018;9:1049.
   PubMed Web of Science ®Google Scholar
• Dragovic S, Gunness P, Ingelman-Sundberg M, et al. Characterization of human cytochrome P450s involved in the bioactivation of clozapine. Drug Metab Dispos. 2013 Mar;41(3):651–658.
   PubMed Web of Science ®Google Scholar
• Dain JG, Nicoletti J, Ballard F. Biotransformation of clozapine in humans. Drug Metab Dispos. 1997 May;25(5):603–609.
   PubMed Web of Science ®Google Scholar
• Arnaud MJ. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handb Exp Pharmacol. 2011;200:33–91.
   Google Scholar
• Hakooz NM. Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities. Curr Drug Metab. 2009 May;10(4):329–338.
   PubMed Web of Science ®Google Scholar
• Kot M, Daniel WA. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with Cdna-expressed P450s including CYP2C isoforms. Biochem Pharmacol. 2008 Aug 15;76(4):543–551. DOI:10.1016/j.bcp.2008.05.025
   PubMed Web of Science ®Google Scholar
• Thorn CF, Aklillu E, Klein TE, et al. PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics. 2012 Jan;22(1):73–77.
   PubMed Web of Science ®Google Scholar
• Zhang HF, Li ZH, Liu JY, et al. Correlation of cytochrome P450 oxidoreductase expression with the expression of 10 isoforms of cytochrome P450 in Human Liver. Drug Metab Dispos. 2016 Aug;44(8):1193–1200.
   PubMed Web of Science ®Google Scholar
• Ozdemir F, Oz MD, Suzen HS. A novel PCR-RFLP method for detection of POR*28 polymorphism and its genotype/allele frequencies in a Turkish population. Curr Drug Metab. 2019;20(10):845–851.
   PubMed Web of Science ®Google Scholar
• Vahia VN. Diagnostic and statistical manual of mental disorders 5: a quick glance. Indian J Psychiatry. 2013 Jul;55(3):220–223.
   PubMed Web of Science ®Google Scholar
• GS FR, Belsey S, Couchman L, et al. Therapeutic monitoring of plasma clozapine and N-desmethylclozapine (norclozapine): practical considerations. BJPsych Adv. 2023;29(2):92–102.
   Google Scholar
• Hagg S, Spigset O, Mjorndal T, et al. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2000 Jan;49(1):59–63.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215. DOI:10.1093/nar/16.3.1215
   PubMed Web of Science ®Google Scholar
• Kotsopoulos J, Ghadirian P, El-Sohemy A, et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):912–916.
   PubMed Web of Science ®Google Scholar
• Rosland M, Szeto P, Procyshyn R, et al. Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography. Drug Dev Ind Pharm. 2007 Oct;33(10):1158–1166.
   PubMed Web of Science ®Google Scholar
• Avenoso A, Facciola G, Campo GM, et al. Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 1998 Sep 4;714(2):299–308. DOI:10.1016/S0378-4347(98)00202-3
   PubMed Web of Science ®Google Scholar
• Swartz ISK ME. Handbook of Analytical Validation. 1st ed. Boca Raton: CRC Press; 2012.
   Google Scholar
• Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011 Sep;44(6):195–235.
   Web of Science ®Google Scholar
• Wohkittel C, Gerlach M, Taurines R, et al. Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice. J Neural Transm (Vienna). 2016 Aug;123(8):1021–1031.
   PubMed Web of Science ®Google Scholar
• Consoli G, Lastella M, Ciapparelli A, et al. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. Pharmacogenomics. 2009 Aug;10(8):1267–1276.
   PubMed Web of Science ®Google Scholar
• Thorn CF, Muller DJ, Altman RB, et al. PharmGKB summary: clozapine pathway, pharmacokinetics. Pharmacogenet Genomics. 2018 Sep;28(9):214–222.
   PubMed Web of Science ®Google Scholar
• Tang YL, Mao P, Li FM, et al. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia. Br J Clin Pharmacol. 2007 Jul;64(1):49–56.
   PubMed Web of Science ®Google Scholar
• Rodrigues-Silva C, Semedo AT, Neri H, et al. The CYP2C19*2 and CYP2C19*17 polymorphisms influence responses to clozapine for the treatment of schizophrenia. Neuropsychiatr Dis Treat. 2020;16:427–432. DOI:10.2147/NDT.S228103
   PubMed Web of Science ®Google Scholar
• Agrawal V, Huang N, Miller WL. Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19. Pharmacogenet Genomics. 2008 Jul;18(7):569–576.
   PubMed Web of Science ®Google Scholar
• Sandee D, Morrissey K, Agrawal V, et al. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. Pharmacogenet Genomics. 2010 Nov;20(11):677–686.
   PubMed Web of Science ®Google Scholar
• Agrawal V, Choi JH, Giacomini KM, et al. Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenet Genomics. 2010 Oct;20(10):611–618.
   PubMed Web of Science ®Google Scholar
• Elens L, Nieuweboer AJ, Clarke SJ, et al. Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin. Pharmacogenet Genomics. 2013 Mar;23(3):148–155.
   PubMed Web of Science ®Google Scholar
• Lunde I, Bremer S, Midtvedt K, et al. The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. Eur J Clin Pharmacol. 2014 Jun;70(6):685–693.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Wang B, Yang LP, et al. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev. 2010 May;42(2):268–354.
   PubMed Web of Science ®Google Scholar
• Ammar H, Chadli Z, Mhalla A, et al. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients. Pharmacogenomics J. 2021 Oct;21(5):551–558.
   PubMed Web of Science ®Google Scholar
• Na Takuathung M, Hanprasertpong N, Teekachunhatean S, et al. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019 Jan;139(1):15–25.
   PubMed Web of Science ®Google Scholar
• Huang HC, Lua AC, Wu LS, et al. Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism. Psychiatr Genet. 2016 Aug;26(4):172–177.
   PubMed Web of Science ®Google Scholar
• van der Weide J, Steijns LS, van Weelden MJ. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics. 2003 Mar;13(3):169–172.
   PubMedGoogle Scholar
• Yartsev A, Peisah C. Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report. BMC Psychiatry. 2021 Apr 13;21(1):192. DOI:10.1186/s12888-021-03199-x
   PubMed Web of Science ®Google Scholar
• Tsuda Y, Saruwatari J, Yasui-Furukori N. Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine. BMJ Open. 2014 Mar 4;4(3):e004216. DOI:10.1136/bmjopen-2013-004216
   PubMed Web of Science ®Google Scholar
• Haslemo T, Eikeseth PH, Tanum L, et al. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. Eur J Clin Pharmacol. 2006 Dec;62(12):1049–1053.
   PubMed Web of Science ®Google Scholar
• de Jonge H, Metalidis C, Naesens M, et al. The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients. Pharmacogenomics. 2011 Sep;12(9):1281–1291.
   PubMed Web of Science ®Google Scholar
• Raaska K, Raitasuo V, Laitila J, et al. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients. Basic Clin Pharmacol Toxicol. 2004 Jan;94(1):13–18.
   PubMed Web of Science ®Google Scholar